IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
FEDERAL LOBBYING RECORDS

LOBBYING FILINGS AND MARKET CONTEXT

Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.

Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies

Clients by reported amount

#ClientFilingsTotal $
1PFIZER INC.PFE48$46.9M
2GENERAL MOTORS COMPANYGM61$46.8M
3META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA13$45.0M
4VISA INC.V46$37.7M
5AMAZON.COM SERVICES LLCAMZN37$32.8M
6LOCKHEED MARTIN CORPORATIONLMT76$29.1M
7FEDEX CORPORATIONFDXW71$27.9M
8ELI LILLY AND COMPANYLLY60$27.4M
9ALTRIA CLIENT SERVICES LLCMO147$25.3M
10COMCAST CORPORATIONCMCSV183$24.9M
11AMGEN INCAMGN19$24.9M
12MERCK & CO INCMRK14$24.0M
13SOUTHERN COMPANYSO54$23.9M
14GOOGLE CLIENT SERVICES LLCGOOGL83$22.8M
15APPLE INCAAPL9$22.1M
16T-MOBILE USA INC.TMUS131$21.3M
17UNITEDHEALTH GROUP INCUNH19$20.4M
18VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ41$20.1M
19OCCIDENTAL PETROLEUM CORPORATIONOXY32$19.8M
20MICROSOFT CORPORATIONMSFT107$18.9M
21QUALCOMM INCORPORATEDQCOM40$17.2M
22BOEING COMPANYBA24$17.0M
23GENERAL DYNAMICS CORPGD11$17.0M
24THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI13$16.9M
25ORACLE CORPORATIONORCL60$16.8M

Mapped tickers by reported amount

#TickerFilingsTotal $
1META
Meta Platforms Inc.
134$50.3M
2PFE
Pfizer Inc.
89$48.7M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
47$37.7M
5AMZN
Amazon.com Inc.
82$35.4M
6LMT
Lockheed Martin Corporation
92$29.5M
7FDX
FedEx Corporation
83$28.4M
8LLY
Eli Lilly and Company
88$28.4M
9AMGN
Amgen Inc.
100$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
66$27.0M
12GOOGL
Alphabet Inc. Class A
128$26.8M
13MO172$26.4M
14SO
Southern Company
110$26.2M
15UNH
UnitedHealth Group Inc.
68$24.0M
16VZ
Verizon Communications Inc.
119$23.8M
17TMUS170$22.9M
18CHTR142$22.8M
19GD
General Dynamics Corporation
131$22.6M
20T
AT&T Inc.
137$21.7M
21ORCL
Oracle Corporation
135$20.8M
22CMCSA
Comcast Corporation
142$20.5M
23OXY
Occidental Petroleum Corporation
38$20.1M
24CI
The Cigna Group
64$19.9M
25MSFT
Microsoft Corporation
126$19.3M

🆕 Filtered Filings · RVTY

clear filters
DateTickerClientRegistrantAmountIssue
2026-07-13RVTYREVVITY INC.REVVITY, INC.$40KDiagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
2026-04-23RVTYREVVITY INC.REVVITY, INC.$35KDiagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act Support for Genetic Screening Proposals related to pandemic preparedness
2026-01-09RVTYREVVITY INC.REVVITY, INC.$30KDiagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
2025-10-02RVTYREVVITY INC.REVVITY, INC.$30KDiagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs Medical Device & Pharmaceutical Adjacent Tariff
2025-04-24RVTYREVVITY INC.REVVITY, INC.$30KDiagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariff
2025-04-24RVTYREVVITY INC.REVVITY, INC.$0SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood tissue and collection and storage payment policies; Pandemic preparedness and prevention policies; Medical Device & Pharmaceutical Adjacent Tariffs. SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T
2025-04-07RVTYREVVITY INC. (FORMERLY PERKINELMER INC.)REVVITY, INC. (FORMERLY PERKINELMER, INC.)$70KDiagnostic test reimbursement and policies; Proposals related to newborn screening; Proposals related to pandemic preparedness; H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses